Riskpilot← Back to searchSign inGet full accessWABBA TREATS AS
ASActiveOrg 923083243Ullevålsveien 51A, 0171 OsloManufacture of other food products n.e.c. · NACE 1089Est. 20190 employees
Revenue 2024
NOK 6M
+932% vs 2023
EBITDA margin
49.9%
+801% vs 2023
Equity ratio
44.6%
Financial strength
Net profit 2024
NOK 2,5M
+543% vs 2023
| Revenue | NOK 6M | +932% |
| EBITDA | NOK 3M | +801% |
| Net profit | NOK 2,5M | +543% |
| Total assets | NOK 4,2M | +177% |
| Equity | NOK 1,9M | +392% |
| Employees | 0 | — |
Legal name
WABBA TREATS AS
Org number
923083243
Legal form
Aksjeselskap
NACE code
1089 · Manufacture of other food products n.e.c.
Founded
12. juli 2019
Share capital
NOK 30 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Livsstilselskap som gjør usunne og kaloririke produktkategorier sunne, kalorifattige og lett tilgjengelige ved bruk av naturlige råvarer. Matvarene kan spises når som helst og hvor som helst, og er passende til ethvert tidspunkt i alle ukens dager. Viktigst av alt er likevel dette matvarene passer for alle, uavhengig av mål og livsstil, og det sunne går aldri på bekostning av smak.
Address
Ullevålsveien 51A, 0171 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 224 | 582 | 6 004 |
| Staff expenses | −0 | −0 | −0 | −211 | −75 |
| EBITDA | −23 | −50 | 114 | −427 | 2 994 |
| Depreciation & amort. | −6 | −14 | −71 | −73 | −85 |
| EBIT | −29 | −64 | 43 | −500 | 2 908 |
| Net financials | −1 | −0 | −40 | −64 | 134 |
| Profit before tax | −30 | −64 | 3 | −564 | 3 043 |
| Tax | −0 | −0 | −0 | −0 | 544 |
| Net profit | −30 | −64 | 3 | −564 | 2 498 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 55 | 702 | 814 | 1 504 | 4 170 |
| Equity | −12 | −77 | −73 | −637 | 1 861 |
| Long-term debt | 0 | 600 | 600 | 1 589 | 1 451 |
| Short-term debt | 67 | 179 | 287 | 553 | 858 |
| Total debt | 67 | 779 | 887 | 2 142 | 2 309 |
EBITDA margin
49.9%
This company
15.8%
Market median
+216% vs market
20202024
Equity ratio
44.6%
This company
38.2%
Market median
+17% vs market
20202024
Return on equity
134.3%
This company
18.4%
Market median
+630% vs market
20202024
Net profit margin
41.6%
This company
8.1%
Market median
+414% vs market
20202024
Asset turnover
1.44×
This company
1.12×
Market median
+29% vs market
20202024
Debt / equity
1.24×
This company
0.62×
Market median
-100% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2019 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100% | 100% | 2022 | |
| Company | 90% | 90% | 2024 | |
Legendman Investment Ltd. | Company | 10% | 10% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of WABBA TREATS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kristian Kyrkjebø Fredheim | Chairman | 0 companies |